Boston Scientific Corporation (NYSE: BSX) announced U.S. Food and Drug Administration approval and launch of two spinal cord stimulation (SCS) lead splitters for use with its Precision Plus™ Spinal Cord Stimulator System, the world’s first rechargeable SCS device for the management of chronic pain of the trunk, back and/or limbs. The W4 and D4 splitters each enable multi-site placement of up to four leads, which are designed to deliver electrical pulses to the spinal cord that mask pain signals to the brain…

Credits to:Health News from Medical News Today

Related Posts

• Medtronic’s Integrity Coronary Stent Gets FDA Approval
  The FDA (Food and Drug Administration, USA) has approved Medronic's Integrity Coronary Stent System, based on an advanced biomedical engineering calle...
• New Community Garden Rules Offer Weaker Protection Than 2002 Agreement: NY State Lead Attorney
  photo: Matthew McDermott To hear NYC Parks Commissioner Adrian Benepe describe it, either on WNYC or in the New York Post, the proposed rules govern...
• Test Of Spinal Fluid Could Mean Earlier Diagnosis Of Alzheimer’s
  An international team of scientists found that a unique "signature" of three proteins present in the spinal fluid of 90 per cent of people with Alzh...
• Society Of Cardiovascular Computed Tomography Announces Recipients Of Fourth Annual Young Investigator Award
  The Society of Cardiovascular Computed Tomography (SCCT), the leading international professional society dedicated to research, education and clinical...
• North Korean Health Care System In A Shocking State
  Imagine a healthcare system in which amputations and major surgeries are performed with no anesthesia, hospitals that do not sterilize needles, hospit...